Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy;Analiza ekspresji molekuł kostymuluja̧cyh (CD28-CTLA-4/B7) na powierzchni wybranych komórek mononuklearnych w grupie młodocianych pacjentów z choroba̧ Gravesa-Basedowa, poddanych terapii metizolem

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 10, Issue 2, 2004, Pages 93-101

  Bossowski, Artur ^a   Stasiak Barmuta, Anna ^b   Urban, Mirosława ^a   Rinderle, Cornelia ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b AM   (Poland)

^c Laboratorium Badawcze   (Germany)

Author keywords

Antithyroid autoantibodies; Costimulatory molecules; Graves' disease; Lymphocytes; Non toxic nodular goiter

Indexed keywords

ANTIGEN; B7 ANTIGEN; BLOCKING ANTIBODY; CD28 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; THIAMAZOLE; THYROID ANTIBODY; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; ANTITHYROID AGENT; CD86 PROTEIN, HUMAN; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; THYROID STIMULATING IMMUNOGLOBULIN;

ADOLESCENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; MONONUCLEAR CELL; NODULAR GOITER; NON TOXIC NODULAR GOITER; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TREATMENT OUTCOME; BLOOD; CASE CONTROL STUDY; CHILD; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; METABOLISM; NONPARAMETRIC TEST; POLAND; REGRESSION ANALYSIS; TIME;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GOITER, NODULAR; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MEMBRANE GLYCOPROTEINS; METHIMAZOLE; POLAND; RECEPTORS, THYROTROPIN; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 8444226676     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ajjan R.A., Kemp E.H., Waterman E.A. i wsp.: Detection of binding and blocking autoantibodies to the human sodium-iodine symporter in patients with autoimmune thyroid disease. J Clin. Endocrinol. Metab., 2000, 85, 2020.
2. Akamizu T., Moriyama K., Miura M. i wsp.: Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs. Endocrinology, 1999, 140, 1594.
3. Ban Y., Davies T.F., Greenberg D.A. i wsp.: Analysis of the CTLA-4, CD28 and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun., 2003, 4, 586.
4. Bolton J., Sanders J., Oda Y. i wsp.: Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin. Chem., 1999, 45, 2285.
5. Bossowski A., Urban M., Staslak-Barmuta A.: Analysis of circulating T gamma/delta lymphocytes and CD16/56 cell populations in children and adolescents with Graves' disease. Pediatr. Res., 2003, 54, 425.
6. Bossowski A., Urban M., Staslak-Barmuta A.: Analysis of changes in the percentage of B (CD 19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J. Paediatr. Endocrinol. Metab., 2003, 16, 1.
7. Damle N., Klussman K., Leytze G. i wsp.: Costimulation of T lymphocytes with intergrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J. Immunol., 1994, 152, 2686.
8. Eguchi K., Matsuoka N., Nagatki S.: Cellular immunity in autoimmune thyroid disease. Baillieres Clin. Endocrinol. Metab., 1995, 9, 71.
9. Fujikawa M., Okamura K., Sato K. i wsp.: Usefulness of surface phenotype study of intrathyroidal lymphocytes obtained by fine needle aspiration cytology in autoimmune thyroid disease and malignant lymphoma of the thyroid. Clin. Endocrinol. (Oxf.), 1998, 49, 191.
10. Heward J., Allahabadia A., Armitage M. i wsp.: The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J. Clin. Endocrinol. Metab., 1999, 84, 2398.
11. Kakinuma A., Morimoto I., Kuroda T. i wsp.: Comparison of recombinant human thyrotropin receptors versus porcine thyrotropin receptors in the thyrotropin binding inhibition assay for thyrotropin receptor autoantibodies. Thyroid, 1999, 9, 849.
12. Kinjo Y., Takasu N., Komiya I., Tomoyose T.: Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of CTLA-4. J. Clin. Endocrinol. Metab., 2002, 87, 2593.
13. Kouki T., Sawai Y., Gardine C.A. i wsp.: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol., 2000, 165, 6606.
14. Kuchroo V.K., Das M.P., Brown J.A.: B7.1 and B7.2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell, 1995, 80, 707.
15. Uu M.F., Yang C.Y., Li K.A. i wsp.: Increased expression of down-regulatory CTLA-4 molecule on T lymphocytes from rheumatoid synovial compartment. Scand. J. Immunol., 1999, 50, 68.
16. Marazuela M.: Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur. J. Endocrinol., 1999, 140, 287.
17. Matsuoka N., Eguchi K., Kawakami A. i wsp.: Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells. J. Clin. Endocrinol. Metab., 1996, 81, 4137.
18. Morgenthaler N.G., Pampel I., Aust G. i wsp.: Application of a Bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor. Horm. Metab. Res., 1998, 30, 162.
19. Park Y., Chung H.K., Park D. i wsp.: Polymorphism in the Promotor and Exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid, 2000, 10, 453.
20. Pozzilli P., Carotenuto P., Delitalia G.: Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity. Clin. Endocrinol., 1994, 41, 545.
21. Roura I.C., Alcalde L., Vargas F. i wsp.: γ/δ Lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes. Clin. Exp. Immunol., 1993, 92, 288.
22. Sansom D., Hall N.: B7/BB1, the ligand for CD28, is expressed on repeatedly activated human cells in vitro. Eur. J. Immunol., 1993, 23, 295.
23. Steiner K., Moosig F., Csernok E. i wsp.: Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis. Clin. Exp. Immunol., 2001, 126, 143.
24. Tomer Y., Greenberg D., Barbesino G. i wsp.: CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J. Clin. Endocrinol. Metab., 2001, 86, 1687.
25. Vaidya B., Imrie H., Perros P. i wsp.: The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum. Mol. Gen., 1999, 8, 1195.
26. Vandenborre K., Van Gool S.W., Kasran A. i wsp.: Interaction of CTLA-4 (CD 152) with CD80 or CD86 inhibits human T-cell activation. Immunology, 1999, 98, 413.
27. Wallaschofski H., Paschke R.: Detection of thyroid stimulating (TSAB) and thyrotrpoin stimulation blocking (TSBAB) antibodies with CHO cell lines expresssing different TSH-receptor numbers. Clin. Endocrinol., 1999, 50, 365.
28. Weetman A.P., Tandon N., Morgan B.P.: Antithyroid drugs and release of inflammatory mediators by complement-attracted thyroid cells. Lancet, 1992, 340, 633.
29. Wyss-Coray T., Mauri-Hellweg D., Baumann K. i wsp.: The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol., 1993, 23, 2175.
30. Yung E., Cheng P.S., Fok T.F., Wong G.W.: CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clin. Endocrinol., 2002, 56, 649.
31. Zaletel K., Krhin B., Gaberscek S. i wsp.: The influence of the exon 1 polymorphism of the CTLA-4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid, 2002, 12, 373.